COVID-19 and Diabetes Mellitus: The Link and Clinical Implications
Dubai Diabetes and Endocrinology Journal · 2020 · 26 (2) · 69-77
DOI: 10.1159/000511354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dubai Diabetes and Endocrinology Journal, online erschienen am 23.10.2020. Verfasst von Chidiebere V. Ugwueze und 5 weiteren Autor:innen. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background: Coronavirus disease 2019 (COVID-19) is a pandemic viral infection that has ravaged the world in recent times, and the associated morbidity and mortality have been much more pronounced in those with noncommunicable disease. Diabetes mellitus is one of commonest noncommunicable diseases associated with worsening clinical status in COVID-19 patients. Summary: The aim of this review was to evaluate the receptors and pathogenetic link between diabetes and COVID-19. Both disease conditions involve inflammation with the release of inflammatory markers. The roles of angiotensin-converting enzyme molecule and dipeptidyl peptidase were explored to show their involvement in COVID-19 and diabetes. Pathogenetic mechanisms such as impaired immunity, microangiopathy, and glycemic variability may explain the effect of diabetes on recovery of COVID-19 patients. The effect of glucocorticoids and catecholamines, invasion of the pancreatic islet cells, drugs used in the treatment of COVID-19, and the lockdown policy may impact negatively on glycemic control of diabetic patients. The outcome studies between diabetic and nondiabetic patients with COVID-19 were also reviewed. Some drug trials are still ongoing to determine the suitability or otherwise of some drugs used in diabetic patients with COVID-19, such as dapagliflozin trial and linagliptin trial.
Zitieren
APA
Ugwueze, C. V., Ezeokpo, B. C., Nnolim, B. I., Agim, E. A., Anikpo, N. C., & Onyekachi, K. E. (2020). COVID-19 and Diabetes Mellitus: The Link and Clinical Implications. Dubai Diabetes and Endocrinology Journal, 26(2), 69-77. https://doi.org/10.1159/000511354
Vancouver
Ugwueze CV, Ezeokpo BC, Nnolim BI, Agim EA, Anikpo NC, Onyekachi KE. COVID-19 and Diabetes Mellitus: The Link and Clinical Implications. Dubai Diabetes and Endocrinology Journal. 2020;26(2):69-77. doi:10.1159/000511354
BibTeX
@article{Ugwueze2020,
author = {Ugwueze, Chidiebere V. and Ezeokpo, Basil Chukwuma and Nnolim, Bede I. and Agim, Emmanuel A. and Anikpo, Nnamdi C. and Onyekachi, Kenechukwu E.},
title = {COVID-19 and Diabetes Mellitus: The Link and Clinical Implications},
journal = {Dubai Diabetes and Endocrinology Journal},
year = {2020},
volume = {26},
number = {2},
pages = {69--77},
doi = {10.1159/000511354}
}
EUVIMED